Fluence Corporation Limited (4SVE) Stock Price & Analysis
4SVE Stock Chart & Stats
- Day’s Range
- EUR 0.04 - EUR 0.04
- 52-Week Range
- EUR 0.03 - EUR 0.08
- Previous Close
- EUR 0.04
- Volume
- 0
- Average Volume (3M)
- 333
- Market Cap
- EUR 39.53M
- Enterprise Value
- EUR 94.35M
- Total Cash (Recent Filing)
- EUR 7.57M
- Total Debt (Recent Filing)
- EUR 21.38M
- Price to Earnings (P/E)
- ―
- Beta
- 0.48
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The 2025 revenue rebound indicates that demand and commercial activity improved after a period of contraction. If maintained, stronger top-line performance can support operating leverage, improve resource utilization, and provide a broader base for restoring profitability over the next several quarters.
Improved Cash Generation
The shift to positive operating and free cash flow is a meaningful improvement in internal funding capacity. Sustained cash generation would reduce reliance on external financing, support investment in the business, and provide greater flexibility despite the company’s ongoing balance-sheet pressures.
Operating Improvement
Positive EBITDA alongside a relatively stable gross margin suggests that operating discipline improved without a major deterioration in underlying economics. Further conversion of this improvement into EBIT and net profit could strengthen the business model and make growth more financially durable.
Bears Say
Negative Equity And Rising Debt
Negative equity materially weakens financial flexibility and makes leverage metrics difficult to interpret. At the same time, higher debt increases refinancing and covenant risk, leaving the company more exposed if operating performance weakens or cash generation fails to remain positive.
Persistent Net Losses
The company has not yet converted its revenue rebound and positive EBITDA into sustainable profitability. Continued EBIT and net losses can erode capital, constrain reinvestment, and require further financing, limiting the durability of the operational recovery over the medium term.
Inconsistent Cash Conversion
Although 2025 free cash flow was positive, the broader history indicates that cash generation has not been consistent. This volatility makes planning and debt management more difficult, and it reduces confidence that recent operating improvements will reliably translate into recurring liquidity.
Fluence Corporation Limited News
4SVE FAQ
What was Fluence Corporation Limited’s price range in the past 12 months?
What is Fluence Corporation Limited’s market cap?
When is Fluence Corporation Limited’s upcoming earnings report date?
How were Fluence Corporation Limited’s earnings last quarter?
Is Fluence Corporation Limited overvalued?
Does Fluence Corporation Limited pay dividends?
What is Fluence Corporation Limited’s EPS estimate?
How many shares outstanding does Fluence Corporation Limited have?
What happened to Fluence Corporation Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Fluence Corporation Limited?
What is the TipRanks Smart Score and how is it calculated?
Fluence Corporation Limited Stock Smart Score
Company Description
Fluence Corporation Limited
Fluence Corporation Limited, together with its subsidiaries, provides smart water and wastewater treatment solutions for the municipal, commercial, and industrial markets worldwide. The company offers water treatment solutions, such as reverse-osmosis desalination, clarification, multimedia filtration, methane removal, arsenic removal, denitrification, uv disinfection, softening, mollusk removal, coagulation and flocculation, flotation, activated carbon filtration, biological filtration, contaminants removal, ultrafiltration, remineralization, and ozonation. It also provides NIROBOX Smart Packaged Water Solutions for seawater and brackish water desalination, as well as freshwater treatment; NIROFLEX, pre-engineered pretreatment and reverse osmosis building blocks for cost-effective seawater desalination systems; and desalination for drinking water, industrial process water desalination, seawater reverse osmosis, and brine management. In addition, the company offers wastewater treatment solutions comprising waste-to-energy and other anaerobic biological solutions, aerobic biological treatment, nutrient removal, wastewater reuse, dissolved air flotation, aeration and mixing solutions, disinfection, sludge treatment, and physico-chemical treatment; membrane aerated biofilm reactors, end-to-end containerized wastewater solutions, aeration equipment, and industrial wastewater treatment; and operates tipton containerized wastewater treatment plants. Further, it provides water and wastewater reuse solutions, including membrane aerated biofilm reactors, anaerobic membrane bioreactors, tertiary treatment for industrial reuse, and containerized water reuse systems; waste-to-energy solutions; and food and beverage processing solutions. Additionally, the company offers field services, spare parts, and consumables; project financing; smart operations; and water management services. Fluence Corporation Limited was incorporated in 2007 and is headquartered in Plymouth, Minnesota.
- Sector
- Industrials
- Industry
- Industrial - Pollution & Treatment Controls
- CEO
- Benjamin A. Fash
- Employees
- 0
- Website
- www.fluencecorp.com
- Address
- 3600 Holly Lane North, Plymouth, MN, 55447, US
Fluence Corporation Limited (4SVE) Earnings & Revenues
4SVE Earnings Call
Earnings Call SentimentPositive
The call highlights a clear operational turnaround: strong revenue growth (+52% y/y), an EBITDA swing to positive ($4.0M vs -$4.0M prior year), record SPS and Recurring Revenue orders, backlog growth, margin improvements since 2022, and improved cash generation and debt repayment. Key challenges include a $4.5M receivable reserve in Egypt, near-term cash timing risk in Q1 2026, concentration of incremental revenue in the Ivory Coast Addendum (a lower-margin project), and limited numerical guidance for FY2026. On balance the positive financial momentum, order strength and structural shift to recurring higher-margin revenue outweigh the noted risks.
View all DE:4SVE earnings summaries4SVE Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 2 | 12 |
| Technical Analysis | 2 | 2 | 3 |
| Moving Averages | 3 | 0 | 9 |